BCAX- Bicara Therapeutics Inc.

Name: Bicara Therapeutics Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Bicara Therapeutics Inc. (BCAX) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. BCAX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Mazumdar Claire	377.2K	$8.76M	-
COO	Cohlhepp Ryan	191.6K	$4.45M	-
CFO	Hyep Ivan	125.0K	$2.90M	-
Other	Meisner Lara	90.0K	$2.09M	-
Other	Raben David	60.8K	$1.41M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 25, 2025	Raben David58	Chief Medical Officer	Sale+OE	11,000	$18.65	$205,108.20	-9.4%	-11.2%	-
Nov 24, 2025	Mazumdar Claire52	Chief Executive Officer	Sale+OE	41,163	$18.86	$776,428.85	-11.7%	-13.1%	-
Nov 24, 2025	Hyep Ivan62	Chief Financial Officer	Sale+OE	18,400	$18.54	$341,074.44	-6.0%	-13.1%	-
Nov 21, 2025	Cohlhepp Ryan52	President And COO	Sale+OE	12,500	$18.05	$225,587.50	-3.1%	-14.5%	-
Oct 16, 2025	Mazumdar Claire52	Chief Executive Officer	Sale+OE	24,103	$18.83	$453,760.67	-7.2%	-3.5%	-
Oct 15, 2025	Cohlhepp Ryan52	President And COO	Sale+OE	12,500	$18.16	$226,942.50	-3.0%	-6.8%	-
Oct 15, 2025	Mazumdar Claire52	Chief Executive Officer	Sale+OE	24,734	$18.88	$466,936.46	-3.8%	-6.8%	-
Oct 9, 2025	Raben David58	Chief Medical Officer	Sale+OE	22,000	$18.45	$405,900.00	-38.3%	-6.0%	-
Oct 9, 2025	Hyep Ivan62	Chief Financial Officer	Sale+OE	6,415	$18.23	$116,931.34	-4.2%	-6.0%	-
Oct 8, 2025	Hyep Ivan62	Chief Financial Officer	Sale+OE	30,385	$18.21	$553,198.15	-6.5%	-10.1%	-

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC